IBRX: ImmunityBio Inc - Common Stock

IBRX News

• Seeking Alpha 10:51 ImmunityBio: High Stakes On ANKTIVA's Growth Amidst FDA Friction And Financial Pressures
• Seeking Alpha 13:09 ImmunityBio: Lymphopenia Opportunity Could Provoke Short Squeeze (NASDAQ:IBRX)
• Investing 18:05 Alibaba, Tesla Lead Market Cap Stock Movers on Wednesday
• Investing 11:37 H.C. Wainwright maintains buy rating on ImmunityBio stock after FDA milestones
• Investing 13:04 ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer
• Investing 14:31 Nvidia, Veeva Surge Among Thursday’s Market Cap Stock Movers
• Investing 12:32 ImmunityBio, Saudi Arabia’s Ministry of Investment, KFSHRC, and KAIMRC Sign Strategic Memorandum of Understanding to Launch Cancer BioShield™ Platform in the Middle East
• Investing 14:31 Amer Sports, Viking Holdings lead Tuesday’s market cap stock movers
• Investing 11:30 Piper Sandler raises ImmunityBio stock rating, target to $5
• Benzinga 17:11 Foot Locker And Archer Aviation Are Among Top 8 Mid-Cap Gainers Last Week (May 12-May 16): Are The Others In Your Portfolio? - Archer Aviation (NYSE:ACHR), Foot Locker (NYSE:FL)
• Benzinga 13:21 ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug - ImmunityBio (NASDAQ:IBRX)
• Benzinga 12:18 Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Guardant Health (NASDAQ:GH), CNA Financial (NYSE:CNA)
• Investing 11:59 ImmunityBio stock sinks after FDA issues RTF letter
• Seeking Alpha 21:54 ImmunityBio: Taking Care Of Business (NASDAQ:IBRX)
• Benzinga 14:15 Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday - Avis Budget Gr (NASDAQ:CAR), Concentrix (NASDAQ:CNXC)
• Seeking Alpha 06:47 ImmunityBio: BCG Shortage And Tariff Risks May Stifle Anktiva’s Commercial Momentum (IBRX)
• Benzinga 18:09 ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug - ImmunityBio (NASDAQ:IBRX)
• Benzinga 14:33 This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - ImmunityBio (NASDAQ:IBRX), Aduro Clean Technologies (NASDAQ:ADUR)
• Investing 21:32 ImmunityBio stock rises on Q4 earnings beat, revenue growth
• Benzinga 17:18 Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday? - SPDR S&P 500 (ARCA:SPY)
• Benzinga 18:20 Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday - Andersons (NASDAQ:ANDE), Analog Devices (NASDAQ:ADI)